Added to YB: 2024-09-30
Pitch date: 2024-09-30
CORT [bullish]
Corcept Therapeutics Incorporated
+28.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Market Cap
$6.1B
Pitch Price
$46.58
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.3K
P/E
141.99
EV/Sales
7.31
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Corcept Therapeutics Incorporated. CORT
A summary for this pitch has not been created yet.
Read full article (0 min)